Bone Therapeutics and Medsenic set to combine in share for share deal
Subject to the outcome of a shareholders’ meeting, Bone Therapeutics and Medsenic are set to…
Subject to the outcome of a shareholders’ meeting, Bone Therapeutics and Medsenic are set to…
A collaboration between Genmab and BioNTech to develop and commercialize immunotherapies for the treatment of…
Drug discovery company C4X Discovery Holdings plc released a report today (August 2) detailing the continued…
An observational study has started enrolling patients with advanced/metastatic non-small cell lung cancer (NSCLC). Florida-based…
Kelun-Biotech and MSD (Merck & Co.) have announced they are entering in a joint license…
Finnish immunotherapy company Valo Therapeutics Oy (ValoTx) has obtained exclusive licensing of intellectual property rights…
A phase 1 trial to investigate a drug for treating people with advanced malignant neoplasms…
A new class of bispecific protein immunotherapy, being developed for patients with human immunodeficiency virus…
Artificial intelligence will be used to perform molecular analysis of biopsies from unidentified Inflammatory Bowel…
An mRNA-technology company developing cancer therapeutics designed to improve patients' survival rate and quality of…
An Italian-based cell therapy business has just been bought by Evotec SE, a German therapeutics…
A Paris-based biotech company developing products for auto-immune diseases, announced today (June 30) that it…